XML 116 R82.htm IDEA: XBRL DOCUMENT v2.4.0.8
Benefit Plans Benefit Plans (Details) (USD $)
12 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2013
Netherlands Benefit Plans
Dec. 31, 2012
Netherlands Benefit Plans
Dec. 31, 2013
U.S. Plan
Dec. 31, 2012
U.S. Plan
Dec. 31, 2011
U.S. Plan
Dec. 31, 2013
International Pension Plans [Member]
Dec. 31, 2012
International Pension Plans [Member]
Dec. 31, 2011
International Pension Plans [Member]
Dec. 31, 2013
Foreign Pension Plans, Defined Benefit in Austria, France, Greece, Italy, Mexico, South Africa, Taiwan, Thailand, and Other
Dec. 31, 2013
Foreign Pension Plans, Defined Benefit in the Netherlands, Germany, India, Korea, and Other
Dec. 31, 2013
International Pension Plans in Other Locations
Mar. 30, 2014
Foreign Pension Plans, Defined Benefit in the Netherlands
Dec. 31, 2013
Multi-employer Plan
Dec. 31, 2012
Multi-employer Plan
Dec. 31, 2011
Multi-employer Plan
Dec. 31, 2013
International Pension Plans Accounted for As Multi-employer Plans
Dec. 31, 2012
Pfizer
U.S. Plan
Dec. 31, 2013
Pfizer
Supplemental Saving Plan
Defined Benefit Plan Disclosure [Line Items]                                          
Defined Benefit Plan, Amount of Service Credit Continuation to be Funded, Percentage             60.00%                            
Defined Benefit Plan, Amount of Service Credit Continuation to be Funded by Related Party, Percentage                                       40.00%  
Defined Benefit Plan, Amount of Service Credit Continuation to be Funded             $ 38,000,000                            
Defined Benefit Plan, Amount of Service Credit Continuation to be Funded by Related Party                                       25,000,000  
Employee benefit plan contribution from Pfizer Inc.(d) 23,000,000 [1]                                        
Defined Benefit Plan, Amount of Service Credit Continuation, Payment Term           10 years                              
Defined Benefit Plan, Amount of Pension and Postretirement Benefit Expense for Certain US Employees           6,000,000                              
Pension and Other Postretirement Benefit Expense 15,000,000 61,000,000 64,000,000     4,000,000 17,000,000 17,000,000               7,000,000 6,000,000 5,000,000      
Defined Benefit Plan, Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets, Aggregate Projected Benefit Obligation                       21,000,000   21,000,000              
Defined Benefit Plan, Benefit Obligation 73,000,000 39,000,000 37,000,000                   73,000,000                
Defined Benefit Plan, Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets, Aggregate Fair Value of Plan Assets 37,000,000 35,000,000                     45,000,000                
Dedicated Pension Plans, Settlement Charge for Contract Termination                             4,000,000            
Defined Benefit Plan, Net Periodic Benefit Cost 4,000,000 2,000,000 3,000,000                                    
Defined Benefit Plan, Actuarial Gain (Loss) (2,000,000) [2] 1,000,000 [2] 5,000,000 [2],[3]                                    
Defined Benefit Plan, Future Amortization of Gain (Loss) 200,000                                        
Defined Benefit Plan, Accumulated Other Comprehensive Income Net Gains (Losses), after Tax 10,000,000 5,000,000   4,000,000 3,000,000                                
Amortization Period For Defined Benefit Plan Gain Loss       12 years 4 months 24 days                                  
Defined Benefit Plan, Contributions by Employer 0 2,000,000             2,000,000 2,000,000 2,000,000         6,000,000 6,000,000 6,000,000 7,000,000    
Defined Benefit Plans, Estimated Future Employer Contributions in Next Fiscal Year                 1,000,000                        
Defined Benefit Plan, Expected Future Benefit Payments, Next Twelve Months           4,000,000     39,000,000                        
Defined Benefit Plan, Expected Future Benefit Payments, Year Two           4,000,000     1,000,000                        
Defined Benefit Plan, Expected Future Benefit Payments, Five Fiscal Years Thereafter           14,000,000     12,000,000                        
Defined Benefit Plan, Liabilities Transferred from Related Party                                         14,000,000
Defined Benefit Plan, Cash Funding Transferred from Related Party                                         9,000,000
Defined Benefit Plan, Deferred Tax Asset Transferred from Related Party                                         5,000,000
Defined Contribution Plan, Employer Matching Contribution, Percent of Match 100.00%                                        
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 5.00%                                        
Defined Contribution Plan Minimum Annual Contributions Per Employee Percent 0                                        
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 8.00%                                        
Defined Contribution Plan, Cost Recognized 35,000,000 20,000,000 18,000,000                                    
Defined Benefit Plan, Expected Future Benefit Payments, Year Three           4,000,000     1,000,000                        
Defined Benefit Plan, Expected Future Benefit Payments, Year Four           4,000,000     1,000,000                        
Defined Benefit Plan, Expected Future Benefit Payments, Year Five           $ 4,000,000     $ 1,000,000                        
[1] Represents contributed capital from Pfizer Inc. associated with service credit continuation for certain Zoetis Inc. employees in Pfizer Inc.'s U.S. qualified defined benefit and U.S. retiree medical plans. See Note 14. Benefit Plans.
[2] Presented net of reclassification adjustments and tax impacts, which are not significant in any period presented. Reclassification adjustments related to benefit plans are generally reclassified, as part of net periodic pension cost, into Cost of sales, Selling, general and administrative expenses, and/or Research and development expenses, as appropriate, in the consolidated and combined statements of income.
[3] Includes impacts from acquisitions from the acquisition date, see Note 3. Basis of Presentation and Note 5. Acquisitions, Divestitures and Certain Investments.